Michel Bernier
About Michel Bernier
Michel Bernier is a Staff Scientist at the National Institute on Aging, NIH, with over 34 years of experience. His research focuses on the molecular mechanisms of chronic low-grade inflammation and its impact on insulin resistance, oncogenesis, and aging.
Work at National Institutes of Health
Michel Bernier has been serving as a Staff Scientist at the National Institute on Aging, NIH since 1990. Over the course of 34 years, he has engaged in research that focuses on the molecular mechanisms by which chronic low-grade inflammation contributes to insulin resistance, oncogenesis, and aging. His work involves collaboration with researchers both in the U.S. and internationally, enhancing the understanding of biochemistry, cellular and molecular biology, and cell signaling.
Education and Expertise
Michel Bernier has an extensive educational background in the fields of chemistry, pharmacology, and cell biology. He earned a B.Sc. in Chemistry from Université de Sherbrooke, followed by an M.Sc. in Pharmacology from the same institution. He completed his Ph.D. in Clinical Sciences - Cell Biology at Université de Montréal. Additionally, he pursued post-doctoral fellowships in Cell Biology at INSERM U.162 and Biological Chemistry at The Johns Hopkins University School of Medicine.
Background
Before joining the National Institute on Aging, Michel Bernier worked as an Assistant Professor at McGill University from 1988 to 1990. His academic journey has provided him with a solid foundation in various scientific disciplines, which he has applied throughout his research career. His focus on chronic low-grade inflammation and its implications for health has been a significant aspect of his professional development.
Research Focus and Contributions
Michel Bernier's research primarily investigates the effects of diet-induced low-grade inflammation on liver function and glucose homeostasis in mammals. His contributions to the field include numerous projects and studies that have resulted in publications in peer-reviewed scientific journals. His work aims to deepen the understanding of the relationship between inflammation and metabolic disorders.